Product logins

Find logins to all Clarivate products below.


Gastrointestinal Endoscopy Devices | Market Insights | Japan | 2023

The Japanese GI endoscopy device market was impacted negatively by the COVID-19 global pandemic, resulting in declines in procedure volumes, units sold, and overall market value in 2020. The market is expected to recover through 2031 with a moderate growth mainly due to the efficiency of nationwide CRC and GI cancer screening programs and high incidence of gastric cancer and CRC cases in the country; however, ASP decline in some segments and lack of product innovation will limit growth opportunities.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for GI endoscopy devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2035 because demand for MIS procedures will rise in line with the country’s rapidly aging population. The adoption of…
Report
ENT Devices – Market Insights – Japan
The Japanese ENT device market is projected to grow at a modest pace over the forecast period, supported by a slight increase in ENT procedure volumes. This growth will be primarily driven by a…
Report
Neurovascular Devices – Market Insights – Japan
The Japanese neurovascular device market will see modest growth through 2035, driven by recent technological and clinical advances, including the introduction of nextgeneration devices, expanding…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…
Report
Dialysis Access Treatment Devices – Market Insights – Japan
The Japanese dialysis access treatment device market will decline modestly through 2035, driven by the decreased patient population requiring dialysis care due to high mortality following COVID-19…